PAIN RESEARCH
Online ISSN : 2187-4697
Print ISSN : 0915-8588
ISSN-L : 0915-8588
最新号
PAIN Research
選択された号の論文の16件中1~16を表示しています
Clinical Section-Reviews
  • Aya Nakae, Chie Kishimoto, Nobuyo Oya, Naoki Nagakura, Yoshitake Fujio ...
    2026 年41 巻1 号 p. 11-22
    発行日: 2026/03/13
    公開日: 2026/03/15
    ジャーナル オープンアクセス
    電子付録

    The 0.7% likelihood of approval for novel analgesics from Phase I represents a systemic crisis hindering resolution of the global opioid epidemic and economic burden. This study identifies causes of this stagnation through a dual–faceted analysis of regulatory trends in Japan and global clinical trial failures between 2015 and 2025. Analysis of the Pharmaceuticals and Medical Devices Agency (PMDA) database revealed approximately 95% of primary endpoints in successful applications rely on unidimensional subjective pain intensity scores, whereas multi–faceted functional indicators represent approximately 5%. Concurrently, global data from Pharmaprojects identified an "Efficacy Wall", with failure rates of 63.4% in Phase II and 56.3% in Phase III. The predominant cause of late–stage discontinuation was a lack of efficacy, suggesting that subjective metrics are insufficient to distinguish therapeutic signals from variable placebo responses amidst high intra–individual variability. To revitalize the pipeline, we propose a paradigm shift focused on four strategic pillars: prioritizing multi–faceted functional outcomes aligned with international bio–psycho–social guidelines, integrating objective biomarkers, such as those monitored via electroencephalography (EEG), to mitigate subjective noise, implementing precision medicine through phenotyping utilizing frameworks such as the ICD–11 to identify high–responder populations, and utilizing real–world data (RWD) to manage the prohibitive costs of extended trials. Furthermore, we emphasize redefining the placebo effect as an endogenous pharmacological mechanism, particularly for evaluating digital therapeutics. Harmonizing these objective and multi–dimensional approaches with regulatory science is essential to bridge the gap between biological innovation and clinical approval, ensuring transformative non–opioid treatments reach patients worldwide.

    Current Analgesic Development / Future Mechanism-Driven Approach Fullsize Image
  • Aya Nakae, Chie Kishimoto, Takako Matsubara, Minoru Narita, Takahiro U ...
    2026 年41 巻1 号 p. 122-132
    発行日: 2026/07/29
    公開日: 2026/08/01
    ジャーナル オープンアクセス

    Chronic pain remains one of the most formidable challenges in modern medicine. This difficulty arises because current research is often fragmented across small cohorts and disconnected measures, hindering reproducible findings and translation of outcomes into actionable knowledge. Biobanks have emerged as promising infrastructures; however, many struggle to maintain long–term scientific productivity and financial sustainability. Consequently, the mere accumulation of biospecimens is often insufficient to ensure continued research impact. This review examines organizational and structural factors determining the sustainability and scientific value of biomedical biobanks. Drawing on lessons from successful large–scale biobanks and documented limitations of smaller repositories, we analyze recurrent determinants of success and failure, such as governance structure, funding strategies, researcher accessibility, and multimodal data integration. We propose conceptual design principles for sustainable pain biobanks. Unlike conventional repositories, future infrastructures should operate as active research platforms integrating clinical, molecular, physiological, imaging, and psychosocial data within a unified framework. Such platforms facilitate efficient researcher access and support the generation of longitudinal, multidimensional datasets. In particular, capturing longitudinal information related to stress, sleep, lifestyle, and social environment provides important context for understanding inter–individual variability in pain. Reframing biobanks as active research infrastructures rather than passive collections provides a critical foundation for more reproducible, mechanistically informed, and translational pain research. In turn, such infrastructures enable a more integrated understanding of chronic pain as a complex disorder shaped by dynamic interactions among biological, psychological, and environmental factors.

    Toward Sustainable Pain Biobanking Fullsize Image
Basic Section-Research Reports
  • Masaki Kato, Kairi Ohmori, Suzuka Touma, Shogo Tokuyama
    2026 年41 巻1 号 p. 78-86
    発行日: 2026/06/11
    公開日: 2026/06/17
    ジャーナル オープンアクセス

    Central post–stroke pain (CPSP) is a frequent aftereffect in stroke patients; however, its underlying pathological mechanisms remain unclear. We previously demonstrated that transient ischemic stroke induced by bilateral common carotid artery occlusion (BCAO) produced mechanical allodynia in mice, which serves as a useful experimental model of CPSP. The present study investigated alterations in the expression of nicotinic acetylcholine (nACh) receptor subunits in the brain using this model. Immunohistochemical analyses revealed that the expression of the α4 subunit was significantly reduced in multiple brain regions of BCAO–induced CPSP model mice, including the cerebral cortex, thalamus, and hypothalamus, whereas that of the α7 subunit remained unchanged. Furthermore, a microinjection of the selective α4β2 nACh receptor agonist RJR–2403 into the lateral hypothalamus (LH) or anterodorsal thalamic nucleus (AD) significantly alleviated BCAO–induced mechanical allodynia. These results indicate that impaired neural signaling via α4–containing nACh receptors may contribute to the pathology of CPSP, and suggest the potential of α4β2 nACh receptors activation in the LH and AD as a therapeutic strategy for CPSP.

    Role of nicotinic acetylcholine receptors in alleviating central post–stroke pain in male mice Fullsize Image
  • Keisuke Ueda, Masayo Okumura, Kaoru Tomomatsu, Tohru Shibutani, Eiji K ...
    2026 年41 巻1 号 p. 87-97
    発行日: 2026/06/22
    公開日: 2026/06/24
    ジャーナル オープンアクセス

    The rat inferior alveolar nerve (IAN) transection model is a neuropathic pain model characterized by the development of ectopic mechanical hypersensitivity in the whisker pad—a region innervated by the intact trigeminal nerve branch II—after transection of the IAN, a branch of the trigeminal nerve branch III. Glial activation is widely observed in the trigeminal nucleus after nerve injury, including in the IAN transection model. However, details of the relationship between glial activation and ectopic mechanical hypersensitivity remain unclear. In this study, we performed an extended analysis of microglial localization in the dorsal horn of the trigeminal nucleus, especially in the caudalis, in IAN transection rats with and without mechanical hypersensitivity in the whisker pad, to determine whether the spatial relationship between microglial activation and trigeminal afferent terminals is associated with the development of ectopic mechanical hypersensitivity. Microglia were preferentially localized to the projection area of the injured IAN, and in rats with mechanical hypersensitivity, their distribution was shifted toward the region associated with the uninjured infraorbital nerve. Compared with the projection areas of each trigeminal branch in the dorsal horn, as determined by c–fos expression after capsaicin administration, our results suggest that the distance between the activated microglia induced by nerve injury and the central terminals of the trigeminal nerve II branch is important for the development of mechanical hypersensitivity in the whisker pad innervated by the intact trigeminal nerve II branch.

    Localization of microglia in the trigeminal nucleus after inferior alveolar nerve transection contributes to mechanical hypersensitivity Fullsize Image
  • Ryo Katayama, Mami Kato, Yasunori Takayama, Masataka Sunagawa
    2026 年41 巻1 号 p. 98-109
    発行日: 2026/06/24
    公開日: 2026/06/27
    ジャーナル オープンアクセス

    TJ–100 (also called daikenchuto) is a multicomponent Japanese traditional medicine, which is widely used for the treatment of gastrointestinal disorders and postoperative bowel dysfunction. Previous studies have suggested that TJ–100 enhances intestinal blood flow and intestinal motility, but the direct ion–channel targets of TJ–100 remain incompletely understood. Several constituents of TJ–100, including hydroxy–α–sanshool, [6]–shogaol, and [6]–gingerol, have been reported to affect transient receptor potential vanilloid 1 (TRPV1) or transient receptor potential ankyrin 1 (TRPA1) channels. In primary sensory neurons, TRPV1 functionally interacts with anoctamin 1 (ANO1, also called TMEM16A), and this interaction enhances neuronal excitability. However, it is unclear whether TJ–100 directly activates TRPV1, subsequently inducing this TRPV1 ⁄ ANO1 functional interaction. In this study, we examined the effects of whole TJ–100 extract using whole–cell patch–clamp recordings in HEK293T cells expressing TRP channels and ANO1. TJ–100 induced TRPV1–dependent currents that were suppressed by capsazepine and absent in mock–transfected cells. In TRPV1 ⁄ ANO1 co–expressing cells, TJ–100 induced extracellular Ca2+–dependent current amplification without directly modulating ANO1. TJ–100 did not evoke detectable TRPA1 currents or modulate TRPV4 currents under the heterologous expression conditions investigated. In addition, hydroxy–α–sanshool evoked only weak TRPV1 currents at 1 mM, whereas the ginger–derived constituents [6]–shogaol and [6]–gingerol induced robust TRPV1 currents at 10 µM. These findings identified a TRPV1–centered, channel–level action of TJ–100 and highlight ginger–derived constituents as potential contributors to TJ–100–induced TRPV1 activation.

    Japanese traditional medicine Daikenchuto (TJ–100) selectively activates TRPV1 leading to ANO1 interaction in heterologous expression systems Fullsize Image
  • Sana Saeed, Nazia Koser, Amber Hassan, Rakan Bokhari, Ayesha Saeed, Hi ...
    2026 年41 巻1 号 p. 133-141
    発行日: 2026/08/24
    公開日: 2026/08/26
    ジャーナル オープンアクセス
    電子付録

    Background: Mefenamic acid is an effective non–steroidal anti–inflammatory drug (NSAID) used for dysmenorrhea and musculoskeletal pain, but its clinical use is limited by poor aqueous solubility, short half–life, and dose–related gastrointestinal adverse effects. Formulation strategies that enhance dissolution and modulate drug release may improve formulation performance and drug delivery characteristics. Objective: This study aimed to develop and physicochemically characterise a thiolated Poloxamer F127–assisted self–nanoemulsifying drug delivery system (Th–Polo–F127 SNEDDS) for mefenamic acid with improved encapsulation, stability, mucoadhesion, and in vitro release behaviour. Methods: SNEDDS were prepared using oleic acid as the oil phase, Tween 80 as the surfactant, and PEG 400 as the co–surfactant. Poloxamer F127 was thiolated using EDC ⁄ NHS chemistry and incorporated into the optimised formulation. The nanoformulation was evaluated for droplet size, polydispersity index (PDI), zeta potential, thermodynamic stability, entrapment efficiency, in vitro drug release, and mucoadhesion. Structural modification was confirmed using FTIR and DSC analyses. Results: The thiolated SNEDDS exhibited a mean droplet size of 215.6 ± 115.7 nm with a PDI of 0.23 and a zeta potential of −19.4 ± 7.16 mV. Entrapment efficiency increased to 82%, while cumulative drug release reached 97% over 72 h at pH 6.8. Mucoadhesion studies demonstrated enhanced interaction with mucin dispersion, consistent with thiol–mediated interfacial interactions. Conclusion: These findings demonstrate improved in vitro physicochemical performance of the Th–Polo–F127 SNEDDS, including enhanced drug entrapment, mucoadhesive interaction, colloidal stability, and sustained release. Further pharmacokinetic, analgesic efficacy, and gastrointestinal safety studies are required to determine whether these formulation–level advantages translate into therapeutic benefit.

    Thiolated Poloxamer F127-Assisted Self-Nanoemulsifying Drug Delivery System for Meenamic Acid: An In Vitro Physicochemical Proof-of-Concept Study Fullsize Image
Clinical Section-Research Reports
  • Nobuhiko Mori, Koichi Hosomi, Ryosuke F Takeuchi, Chanseok Lim, Hui Mi ...
    2026 年41 巻1 号 p. 1-10
    発行日: 2026/02/05
    公開日: 2026/02/08
    ジャーナル オープンアクセス

    Background: Neuropathic pain is associated with changes in motor cortical representation and corticospinal excitability. Transcranial magnetic stimulation (TMS), a noninvasive method to stimulate the cortex, allows for detailed evaluation of motor cortical function. TMS–based motor mapping offers insights into alterations in motor cortical representations, but their relationship with pain severity remains unclear. Purpose: This study aimed to investigate the correlation between pain intensity and motor cortical representation in individuals with neuropathic pain through TMS motor mapping. Methods: Fourteen patients with chronic neuropathic pain in the upper limbs underwent TMS motor mapping. Parameters measured included resting motor threshold (RMT), mapped area (area eliciting motor evoked potentials ≥50 µV), and Distance50 (distance from the center of gravity to the estimated location of a 50 µV response). The ratio of the affected to unaffected hemispheres (AH/UH) was calculated. Pain intensity was assessed using the visual analog scale (VAS), numerical rating scale, and short–form McGill pain questionnaire 2. Results: A substantial negative correlation was identified between VAS scores and the AH/UH ratio of the map area (rs = –0.68, p = 0.01), suggesting that increased pain was linked to a reduced motor representation in the affected hemisphere. Conversely, no significant interhemispheric variances or associations with pain intensity were noted for the RMT or Distance50. Conclusions: The findings indicate that alterations in corticospinal excitability play a role in the pathophysiology of neuropathic pain. TMS motor mapping holds promise as a valuable biomarker for comprehending the pathophysiology of neuropathic pain and assessing treatment effectiveness.

    Exploratory evaluation of motor cortical representation in neuropathic pain using TMS mapping Fullsize Image
    This study aimed to investigate the correlation between pain intensity and motor cortical representation in individuals with neuropathic pain using navigation-guided transcranial magnetic stimulation (TMS) motor mapping.
  • Yu Kono, Tomoko Mae, Seiji Hattori
    2026 年41 巻1 号 p. 27-36
    発行日: 2026/04/06
    公開日: 2026/04/12
    ジャーナル オープンアクセス
    電子付録

    Intrathecal analgesia (ITA) is often administered to patients with cancer receiving high–dose systemic opioids. However, in some patients, opioid escalation is challenging even at relatively low doses owing to adverse effects, despite inadequate analgesia. This retrospective study evaluated the effectiveness of neuraxial analgesia and subsequent clinical outcomes in patients with cancer pain who had difficulty tolerating systemic opioid therapy. Among 158 patients who underwent ITA between January 2021 and March 2025, 53 patients with oral morphine equivalents (OME) <200 mg/day were included and followed until death. Pain scores (numerical rating scale [NRS] scores), medication dose changes, home discharge outcomes, survival after ITA, and adverse events were analyzed. Epidural analgesia (EPI) preceded ITA in 52 patients. Median NRS significantly improved from 8 (6–10) before neuraxial analgesia to 1 (0–2) at 2 weeks after ITA (P < 0.001). Median systemic OME decreased from 40 mg/day to 0 mg/day (P < 0.001). Overall, 66% of patients returned home at least once, and 47% died at home. Survival after ITA tended to be shorter in patients with gastrointestinal cancers, whereas greater variability was observed in patients with urinary tract cancers. In patients with cancer pain that was difficult to manage with systemic opioid therapy, stepwise neuraxial analgesia with epidural and intrathecal approaches was associated with substantial pain reduction. Neuraxial analgesia may be considered a therapeutic option in selected patients who are unable to achieve adequate pain control with conventional systemic therapy.

    Neuraxial analgesia may represent a therapeutic option for cancer pain when systemic opioid therapy fails to provide adequate pain control. Fullsize Image
  • Naoto Takahashi, Kozue Takatsuki, Satoshi Kasahara, Ko Matsudaira, Sho ...
    2026 年41 巻1 号 p. 37-43
    発行日: 2026/05/08
    公開日: 2026/05/10
    ジャーナル オープンアクセス

    Background: Although multidisciplinary pain treatment is effective for chronic pain, there may be treatment challenges when severe pain significantly impairs daily life activities. Purpose: To determine whether the degree of daily life impairment caused by pain influences treatment outcomes. Methods: The study comprised 123 patients treated between July 2019 and June 2024. The cutoff scores for pain intensity (assessed using the numerical rating scale) and daily life disability (assessed using the Pain Disability Assessment Scale) were ≥ 5 and ≥ 40, respectively. Patients with chronic pain who exceeded these thresholds at their initial visit were categorized as the severe group (n = 15), whereas those who scored below these thresholds were classified as the non–severe group (n = 108). Psychosocial factors related to pain (measured by the Pain Catastrophizing Scale [PCS], Hospital Anxiety and Depression Scale [HADS], Pain Self–Efficacy Questionnaire, and Athens Insomnia Scale [AIS]) and quality of life (measured by the EuroQol Five Dimensions Questionnaire [EQ–5D]) were used as outcomes. Group comparisons were conducted at baseline and longitudinally over 6 months. Results: At baseline, all measures except the PCS score (rumination) differed significantly between groups. Over the subsequent 6 months, the non–severe group exhibited significant improvements across all outcomes. In contrast, the severe group demonstrated significant improvements in only the HADS (anxiety), EQ–5D, and AIS scores. Conclusion: Patients with severe pain at baseline exhibited limited treatment effects despite multidisciplinary treatment. These findings suggest that higher pain intensity and greater impairment in daily life are predictive of poorer treatment effectiveness.

    Descriptive statistics of the initial examination of the severe and non-severe groups Fullsize Image
  • Akihiro Yamamoto, Koichi Hosomi, Keiko Yamada, Nobuhiko Mori, Hui Ming ...
    2026 年41 巻1 号 p. 57-68
    発行日: 2026/05/28
    公開日: 2026/05/30
    ジャーナル オープンアクセス
    電子付録

    Shibire, a common Japanese term for abnormal somatosensory experience, often coexists with pain. Its ambiguity impedes clinical communication and research. We investigated the interpersonal differences in Shibire’s definitions and prevalence in a Japanese cohort. A nationwide internet–based survey of 1,000 Japanese adults was conducted. Participants defined Shibire by endorsing one or more of three components: Positive sensory symptoms (PSS), Negative sensory symptoms (NSS), and Perceived motor weakness (PMW). We also assessed the prevalence and intensity of Shibire and coexisting pain using a Numerical Rating Scale (NRS), and characterized coexisting pain using the Short–Form McGill Pain Questionnaire 2 (SF–MPQ–2). The point prevalence of Shibire was 22.5%. Among the 581 valid respondents, the most frequently endorsed component for the definition of Shibire was PSS (85.7%), followed by PMW (64.5%), and NSS (56.5%). While Shibire could be defined by a single component or a combination of components, the largest subgroup (37.9%) defined it as a combination of all three components. The overall intensity of Shibire correlated most strongly with PSS intensity (ρ = 0.79), and multiple regression analysis identified PSS as the factor most strongly associated with Shibire intensity (β = 0.64). The NSS component correlated with the SF–MPQ–2 "numbness" descriptor. Individuals perceive Shibire as a complex, multicomponent experience or a single sensation. Shibire is a multifaceted term that covers the positive sensory, negative sensory, and motor domains. Its high prevalence is a significant public health concern. To ensure accurate diagnosis and research, clinicians should deconstruct the complaint of Shibire by asking patients to specify its components.

    An Internet-Based Survey on the Definition of Shibire Fullsize Image
    Shibire is a common Japanese term for abnormal somatosensory experience, which often coexists with pain.
  • Naoto Takahashi, Shoji Yabuki
    2026 年41 巻1 号 p. 69-77
    発行日: 2026/06/04
    公開日: 2026/06/05
    ジャーナル オープンアクセス

    The Pain Management Center at our hospital provides a multidisciplinary outpatient program for chronic pain. Although improving quality of life is the primary goal, pain reduction is also desirable; however, psychosocial predictors of pain change remain unclear. This cohort study examined whether baseline psychosocial factors predict clinically meaningful pain improvement at 6 months. We analyzed 98 patients with chronic pain who completed questionnaires at baseline and 6 months between April 2015 and March 2023. Pain severity was measured using the Brief Pain Inventory (average pain), and improvement was defined as a ≥2–point reduction from baseline to 6 months. Baseline psychosocial factors and quality of life were assessed using validated scales (Pain Catastrophizing Scale, Pain Disability Assessment Scale, Hospital Anxiety and Depression Scale, Pain Self–Efficacy Questionnaire, Athens Insomnia Scale, 25–question Geriatric Locomotive Function Scale, Brief Scale for Psychiatric Problems in Orthopaedics Patients, and EuroQol–5D). Patients were classified as improved or non–improved, and multivariable logistic regression was performed after evaluating collinearity among candidate predictors. Age, sex, and ICD–11 classification did not differ between groups. In the multivariable model, the rumination subscale of the Pain Catastrophizing Scale was independently associated with pain improvement (odds ratio 0.869, 95% CI 0.757–0.998), indicating lower baseline rumination was associated with higher odds of pain improvement. Rumination may therefore be an important target for assessment and intervention at the initial visit.

    Results of the logistic regression analyses Fullsize Image
Clinical Section-Short Communications
  • Kazuhiro Shimo, Satoshi Ohga, Takafumi Hattori, Takako Matsubara
    2026 年41 巻1 号 p. 142-146
    発行日: 2026/09/28
    公開日: 2026/10/01
    ジャーナル オープンアクセス

    Previous meta–analyses examining attentional bias toward pain–related stimuli in chronic pain have reported small and heterogeneous effects, possibly because pain–explicit stimuli capture attention regardless of pain status. This study used an eye–tracking system to examine whether individuals with low back pain (LBP) show increased visual attention to lifting–related movement scenes. Twelve university students (six with self–reported chronic LBP and six pain–free individuals) viewed paired images depicting a person lifting a load and the same person standing beside the load. Fixation time on the lifting stimulus was longer in the LBP group than in the pain–free group (p = 0.016, r = 0.833). The attentional bias index, calculated as lifting fixation time minus control–stimulus fixation time, was also higher in the LBP group (p = 0.041, r = 0.722). This exploratory study provides preliminary evidence of greater visual attention to lifting–related scenes in individuals with self–reported chronic LBP.

    Context-dependent attentional bias to lifting-related images in low back pain: an eye-tracking study Fullsize Image
    This study used an eye-tracking system to examine whether individuals with low back pain (LBP) show increased visual attention to lifting-related movement scenes.
  • Masashi Izumi, Shota Oda, Yoshihiro Hayashi, Takako Matsubara, Katsuyu ...
    2026 年41 巻1 号 p. 147-151
    発行日: 2026/10/14
    公開日: 2026/10/16
    ジャーナル オープンアクセス
    電子付録

    Quantitative sensory testing (QST) enables a standardized assessment of somatosensory function; however, its clinical use is often limited by time and equipment requirements. This study aimed to establish normative values and standard deviations for a simplified bedside QST toolkit, QuantiPain®, in healthy Japanese participants. A total of 277 healthy volunteers underwent assessments of pressure pain threshold (PPT), temporal summation of pain (TSP), and conditioned pain modulation (CPM). Mean values and standard deviations (±1 SD and ±2 SD) were calculated. PPT showed significant main effects of age and sex without interaction, whereas TSP and CPM were not influenced by these factors, allowing the presentation of pooled values for the three tests. These normative data support the clinical application of QuantiPain® in identifying altered sensory processing and facilitating personalized pain assessment in routine practice.

    Normative values and standard deviations for quantitative sensory testing using a simple bedside tool kit (QuantiPain®) in healthy Japanese subjects Fullsize Image
Basic Section-Micro Reports
Basic Section-Mini Reviews
  • Takashi Suto
    2026 年41 巻1 号 p. 110-121
    発行日: 2026/06/23
    公開日: 2026/06/27
    ジャーナル オープンアクセス

    Chronic pain leads to anatomical and functional alterations in the spinal cord and brain in both animals and humans. The changes in the spinal cord represent a form of central sensitization that can worsen pain. Chronic pain is also associated with cognitive deficits due to brain dysfunction. The mechanisms underlying these symptoms, however, have not yet been fully elucidated. In the early phase after peripheral nerve injury, spinal noradrenergic and cholinergic tone increases, thereby enhancing inhibitory signaling. These signals diminish over time, however, along with the loss of stimulus–evoked activation of the locus coeruleus. In the later phase, animals with neuropathic pain exhibit reduced endogenous analgesia mediated by both noradrenergic and cholinergic pathways. These changes impair the resolution of acute pain, reduce analgesic drug efficacy for neuropathic pain, and impair noradrenaline–mediated brain function. Nerve injury also alters cholinergic, gamma–aminobutyric acid, and dopaminergic systems in the brain, contributing to impaired brain function. Spontaneously hypertensive rats and 6–hydroxydopamine–treated mice exhibit attention deficit hyperactivity disorder (ADHD)–like behaviors and altered pain modulation due to changes in the noradrenergic or dopaminergic systems, even in the absence of nerve injury. A link between ADHD and chronic pain has also been observed in humans, suggesting that shared neurological mechanisms underlie both conditions. This review presents experimental findings of spinal and brain alterations in the chronic neuropathic pain model. Comprehensive investigations to elucidate the reciprocal interactions are crucial for developing effective treatments and preventive strategies for chronic pain and its associated symptoms.

    Alterations of pain modulation following neuropathic pain and their implications for brain function and analgesic efficacy Fullsize Image
Clinical Section-Mini Reviews
  • Lester E Jones
    2026 年41 巻1 号 p. 44-56
    発行日: 2026/05/25
    公開日: 2026/05/27
    ジャーナル オープンアクセス

    This narrative review focuses on published work that has explored and applied a biopsychosocial conceptualisation of pain. Biomedical or pathoanatomical approaches to pain are inadequate, failing to explain the inter–individual variability in response to noxious stimuli, the inconsistent relationship between pain and tissue health and the large numbers of people with pain without an attributable pathology. Pain is biopsychosocial in nature and health professionals need to adopt more sophisticated strategies for clinical reasoning to improve pain assessment and management. Instead of a direct link to pain and tissue injury, it has been proposed that pain is responding to a need state, related to tissue injury and recovery. Recognising research that links life experiences of adversity to pain vulnerability, the review offers a reinterpretation of this proposition and critically evaluates the commonly used dichotomy of acute versus chronic pain. Finally, a summary of clinical reasoning tools is presented to support a biopsychosocial way of thinking and practicing, with a trauma–informed strategy to emphasise the need for early, appropriate and targeted intervention, to avoid unnecessary pain–related suffering and disability.

    Lester Jones (2022) Towards a trauma-informed approach to pain Fullsize Image
feedback
Top